Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult–onset nonautoimmune diabetes
<p><strong>OBJECTIVE</strong> Maturity-onset diabetes of the young (MODY) due to variants in HNF1A is the commonest type of monogenic diabetes. Frequent misdiagnosis results in missed opportunity to use sulfonylureas as first-line treatment. A nongenetic biomarker could improve sel...
Main Authors: | Juszczak, A, Pavić, T, Vučković, F, Bennett, A, Shah, N, Pape Medvidović, E, Groves, C, Šekerija, M, Chandler, K, Burrows, C, Rojnić Putarek, N, Vučić Lovrenčić, M, Ćuća Knežević, J, James, T, Gloyn, A, Lauc, G, McCarthy, M, Owen, K, Gornik, O |
---|---|
Format: | Journal article |
Udgivet: |
American Diabetes Association
2018
|
Lignende værker
-
Maturity onset diabetes of the young due to HNF1A variants in Croatia
af: Pavić, T, et al.
Udgivet: (2018) -
Comparison of 2-Aminobenzamide, Procainamide and RapiFluor-MS as Derivatizing Agents for High-Throughput HILIC-UPLC-FLR-MS N-glycan Analysis
af: Toma Keser, et al.
Udgivet: (2018-07-01) -
Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
af: Gordan Lauc, et al.
Udgivet: (2010-12-01) -
In a pursuit of optimal glycan fluorescent label for negative MS mode for high-throughput N-glycan analysis
af: Dinko Šoić, et al.
Udgivet: (2022-10-01) -
Fucosylated N-glycans as early biomarkers of COVID-19 severity
af: Beatrix Paton, et al.
Udgivet: (2023-06-01)